The cryptococcal antigen lateral flow assay is a type of an immunochromotography test system, used to identify the capsular polysaccharide antigens of cryptococcus species present in serum and Cerebrospinal Fluid (CSF). The combinational use of immunoassay and chromatography has made revolutionary changes in the point of care diagnosis of cryptococcal fungi. The patient are allowing to monitor the presence of fungal infection through one strip of lateral flow assay test. These test are gaining popularity across major developed countries of North America and Europe, owing to their simple operating procedure as compared to other assay techniques. Moreover, the high accuracy and sensitivity with least lead time to produce outcome are providing opportunities for early stage development products.
Cryptococcal Antigen Lateral Flow Assay Test Market: Drivers and Restraints
Increasing incidence of cryptococcal infection, long waiting time to get test results, limited efficacy of substitute techniques would collective drive the growth of cryptococcal antigen lateral flow assay test market. Moreover, the active initiative from the government in Africa countries would provide boost to the market growth. However, limited awareness for cryptococcal antigen lateral flow assay test, and lack of skill work force would limit the adoption of cryptococcal antigen lateral flow assay test.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1227
Cryptococcal Antigen Lateral Flow Assay Test Market: Segmentation
The global cryptococcal antigen lateral flow assay test market is segmented based on, instruments, test location, and end use.
Based on Instruments, the global cryptococcal antigen lateral flow assay test market is segmented into the following:
- Lateral Flow Readers
- Kits and Reagents
Based on test location, the global cryptococcal antigen lateral flow assay test market is segmented into the following:
- Home testing
- Point of care testing
- Laboratory Testing
Based on end use, the global cryptococcal antigen lateral flow assay test market is segmented into the following:
- Diagnostic laboratories
- Ambulatory clinics
- Home healthcare
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1227
Cryptococcal Antigen Lateral Flow Assay Test Market: Overview
Based on instruments, lateral flow readers would experience flourishing innovations in terms of monitoring and control of test sample. Moreover, the lateral flow readers with high specificity and sensitivity with multiple test sample detection feature would gain prominence in future. The market for reagents and media would increase with healthy CAGR, owing to growing use of lateral flow readers in developing and underdeveloped countries. Based on test location, the laboratories would remain prominent for next five years, however, increasing awareness of lateral flow assays in point of care testing would eventually decrease its dominance in laboratories. Based on end use, diagnostic laboratories have prominent market share owing to limited awareness for lateral flow assay technique. However, the growing use of lateral flow assays point of care and home healthcare would surpass the diagnostic laboratories during the forecast period.
Cryptococcal Antigen Lateral Flow Assay Test Market: Region-wise Outlook
Based on geography, the cryptococcal antigen lateral flow assay test market is segmented into North America, Europe, Asia Pacific, and MEA. The commercial success of Cryptococcal Antigen Lateral Flow Assay Test would benefit the African countries, especially in sub-Saharan Africa owing to higher incidence rate of cryptococcosis infections. Hence, the Cryptococcal Antigen Lateral Flow Assay Test Market would witness attractive demand from the middle and African countries, followed by Asia Pacific region. The developed regions are the early adopter of this technology and hence, would represent healthy market share in 2015.
Cryptococcal Antigen Lateral Flow Assay Test Market: Key Players
Key players profiled in this report includes, Kestrel Biosciences LIC, Alere, Inc., BioMerieux, Danaher Corporation, Forsite Diagnostics, Merck Millipore, Qiagen, Roche Diagnostics, Hologic (Gen-Probe), and Siemens Healthcare. These players are focusing oin the development more advanced and more convenient instrument to cater the need to point of care testing and home healthcare testing application.